meta_pixel
Tapesearch Logo
Log in
Behind The Knife: The Surgery Podcast

Journal Review in Minimally Invasive Surgery: Achalasia

Behind The Knife: The Surgery Podcast

Behind The Knife: The Surgery Podcast

Science, Health & Fitness, Medicine, Education

4.81.4K Ratings

🗓️ 31 July 2025

⏱️ 20 minutes

🧾️ Download transcript

Summary

Today, we’re diving into a condition that’s as fascinating as it is complex: Achalasia—where the esophagus stops playing nice, and swallowing becomes a daily challenge.

We’re breaking down the latest evidence, comparing POEM, pneumatic dilation, and Heller myotomy, and digging into what actually matters when deciding how to treat each achalasia subtype.

Join show hosts Drs. Jake Greenberg, Dana Portenier, Zach Weitzner, and Joey Lew as they discuss the past, present, and future of Achalasia management. Whether you're a medical student or a seasoned attending, this episode will arm you with the tools to think critically about diagnosis, tailor your treatment strategy, and stay ahead of the curve on the future of achalasia care.

Hosts: 
·      Jacob Greenberg, MD, EdM, MIS Division Chief and Vice Chair for Education, Duke University
·      Dana Portenier, MD, MIS Fellowship Director, Duke University
·      Zachary Weitzner, MD, Minimally Invasive and Bariatric Surgery Fellow, Duke University, @ZachWeitznerMD
·      Joey Lew, MD, MFA, Surgical resident PGY-3, Duke University, @lew__actually

Learning Goals: 
By the end of this episode, listeners will be able to:
·      Describe the pathophysiology and key diagnostic criteria for achalasia, including the role of manometry, EGD, and esophagram.
·      Differentiate between the three subtypes of achalasia based on the Chicago Classification and understand the clinical significance of each.
·      Compare treatment options for achalasia—pneumatic dilation, Lap Heller myotomy, and POEM—including indications, efficacy, and long-term outcomes.
·      Interpret landmark studies (e.g., European Achalasia Trial, JAMA POEM trial) and their impact on treatment decision-making.
·      Recognize patient-specific factors (age, comorbidities, achalasia subtype) that influence the choice of therapy.
·      Discuss evolving technologies and future directions in achalasia management, including endoluminal robotics, ARMS, and combined anti-reflux strategies.
·      Outline a basic treatment algorithm for newly diagnosed achalasia, incorporating diagnostic steps and tailored interventions.
·      Appreciate the multidisciplinary approach to achalasia care, including the roles of MIS surgeons, gastroenterologists, and emerging procedural skillsets.

References:
·      Boeckxstaens G, Elsen S, Belmans A, Annese V, Bredenoord AJ, Busch OR, Costantini M, Fumagalli U, Smout AJPM, Tack J, Vanuytsel T, Zaninotto G, Salvador R; European Achalasia Trial Investigators. 10‑year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomy. Gut. 2024 Mar;73(4):582‑589. doi: 10.1136/gutjnl‑2023‑331374. PMID: 38050085 https://pubmed.ncbi.nlm.nih.gov/38050085/
·      He J, Yin Y, Tang W, Jiang J, Gu L, Yi J, Yan L, Chen S, Wu Y, Liu X.
Objective Outcomes of an Extended Anti‑reflux Mucosectomy in the Treatment of PPI‑Dependent Gastroesophageal Reflux Disease (with Video). J Gastrointest Surg. 2022 Aug;26(8):1566–1574. doi:10.1007/s11605‑022‑05396‑9. PMID: 35776296 https://pubmed.ncbi.nlm.nih.gov/35776296/
·      Modayil RJ, Zhang X, Rothberg B, et al. Peroral endoscopic myotomy: 10-year outcomes from a large, single-center U.S. series with high follow-up completion and comprehensive analysis of long-term efficacy, safety, objective GERD, and endoscopic functional luminal assessment. Gastrointest Endosc. 2021;94(5):930-942. doi:10.1016/j.gie.2021.05.014. PMID: 33989646. https://pubmed.ncbi.nlm.nih.gov/33989646/
·      Ponds FA, Fockens P, Lei A, Neuhaus H, Beyna T, Kandler J, Frieling T, Chiu PWY, Wu JCY, Wong VWY, Costamagna G, Familiari P, Kahrilas PJ, Pandolfino JE, Smout AJPM, Bredenoord AJ.
Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial. JAMA. 2019 Jul 9;322(2):134–144. doi:10.1001/jama.2019.8859. PMID: 31287522. https://pubmed.ncbi.nlm.nih.gov/31287522/
·      Vaezi MF, Pandolfino JE, Yadlapati RH, Greer KB, Kavitt RT; ACG Clinical Guidelines Committee.
ACG clinical guidelines: Diagnosis and management of achalasia. Am J Gastroenterol. 2020 Sep;115(9):1393–1411. doi:10.14309/ajg.0000000000000731. PMID: 32773454; PMCID: PMC9896940 https://pubmed.ncbi.nlm.nih.gov/32773454/
·      West RL, Hirsch DP, Bartelsman JF, de Borst J, Ferwerda G, Tytgat GN, Boeckxstaens GE. Long term results of pneumatic dilation in achalasia followed for more than 5 years. Am J Gastroenterol. 2002;97(6):1346-1351. doi:10.1111/j.1572-0241.2002.05771.x. PMID:12094848. https://pubmed.ncbi.nlm.nih.gov/12094848/

Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Transcript

Click on a timestamp to play from that location

0:00.0

Behind the Night, the Surgery podcast, relevant and engaging content designed to help you Behind the Night.

0:23.9

This is Jason here.

0:25.0

If you're prepping for the complex general surgical oncology boards

0:27.8

or just looking to level up your surge oncology game,

0:30.3

you need to check out our surgical oncology board review.

0:33.1

This isn't some lame review with just flashcards and outlines.

0:36.6

We've created comprehensive high-yield

0:38.5

scenarios covering the most tested diseases, plus expert commentary and updated guidelines that actually

0:44.4

stick and are proven to help you pass the boards. Breast, pancreas, sarcoma, you name it,

0:49.3

we've got you covered. Available on our app so you can review anytime, anywhere. Group discounts are available. Enjoy the episode and dominate the day. Hi, and welcome back to Behind the Knife. I'm Joey, a second-year surgical resident at Duke, here with the MIS Behind the Knife team to discuss the treatment of acolygia. I'm joined by Dr. Zach Weitzner, our MIS fellow, Dr. Jake Greenberg, the head of our division and vice chair for education, and Dr. Dana Portnear, one of our senior faculty and MIS fellowship director.

1:17.1

Hi, I'm Jake Greenberg, and today we're going to be talking about ekeleasia, so let's dive right in.

1:22.5

So understanding that many of our listeners probably know the answers to these next few questions, Joey, what do I need to diagnose ecolasia and what tests help us diagnose it? So you need to know that

1:33.1

their lower esophageal sphincter doesn't relax. There's an absence of organized parasolsis, and there

1:37.9

isn't a mass stricter or another structural explanation for your findings. The gold standard for

1:43.0

diagnosis is esophageal monometry with an EGD.

1:46.6

Okay, so let's say our patient meet those criteria, but we want to further classify them.

1:51.5

Joey, are there any different types of ecalasia? Yes, so the Chicago classification breaks down

1:56.9

acalasia into three types based on peristolsus, spasm with swallows, and integration relaxation pressure, or IRP, which is a measurement taken during monometry that assesses how well the lower esophageal sphincter relaxes. So if a patient's lower esophageal sphincter does not adequately relax, you'll have a higher than normal pressure, greater than 15 millimeters mercury. And if you have an IRP greater than 15 and failed peristolsus, you have type 1 acalasia. If you have both of those things in panasopageal pressurization, which is another monometry finding and 20% of swallows, you'll have type 2 acalasia. And if you have all three of those things, as well as spastic and distal contractions, you'll have type 3 acalasia. So type 3 is also known as spastic acalasia.

2:36.6

Great. Zach, does it matter what kind the patients have? It's crucial to properly recognize

2:42.1

the different types of acalasia because treatment recommendations vary based on disease type.

2:46.8

Per oral endoscopic myotomy or poem is the treatment of choice for type 3 acalasia, because it allows for an extended myotomy in the setting of panesophageal pressurization and distal spasms. Types 1 and 2 are treated with either halermiotomy or poem. Okay. Great. So once we identify the subtype, what else do we need to know about our patient? We need to know about their medical comorbidities, their baseline functional status, and other factors that affect their surgical candidacy.

3:12.4

This matters because while some less invasive procedures such as pneumatic dilation or Botox injection may be considered less durable and effective,

...

Transcript will be available on the free plan in 4 days. Upgrade to see the full transcript now.

Disclaimer: The podcast and artwork embedded on this page are from Behind The Knife: The Surgery Podcast, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Behind The Knife: The Surgery Podcast and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.